KHOI M DAO MD NPI 1518071208

NPI Information

  • NPI: 1518071208
  • Provider Name: KHOI M DAO, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 10001 S EASTERN AVE STE 108
    HENDERSON, NV
    ZIP 89052
  • Phone: (702) 952-3444

Map and Directions

Get Directions

NPI Details

Khoi M Dao, MD is a hematology and oncology internal medicine in Henderson, NV with 32 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Khoi M Dao, MD NPI is 1518071208. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1994

The provider's business location address is:

10001 S EASTERN AVE STE 108
HENDERSON, NV
ZIP 89052-908
Phone: (702) 952-3444
Fax: (702) 952-3494

The NPI 1518071208 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Blood test, clotting time (HCPCS:85610)
  • Nephelometry, test method using light (HCPCS:83883)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Protein measurement, serum (HCPCS:84165)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Red blood count, automated test (HCPCS:85045)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Unclassified drugs (HCPCS:J3490)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Folic acid level, serum (HCPCS:82746)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Thyroid hormone, t3 measurement, free (HCPCS:84481)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)

The enumeration date for this NPI number is 8/18/2006 and was last updated on 2/29/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology9428NEVADAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1820000366OTHERRAILROAD MEDICARE
2002018375MEDICAIDNEVADA
3820000366OTHERNEVADARAILROAD MEDICARE

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.